All ArticlesCompany news
Company news

Carrot welcomes former SART president, G. David Ball, PhD

By
Carrot
David Ball, PhD
Apr 20, 2022
Share on LinkedIn

At Carrot, our medical team drives clinical strategy to ensure our members receive the most recent, evidence-based, and high-quality education and care navigation. Led by Carrot Co-founder and Chief Medical Officer, Asima Ahmad, MD, MPH, the team is comprised of global fertility healthcare experts with many years of combined experience inside some of the top clinics in the world, as well as deep experience at hospitals in neonatal intensive care units and in urology.

Today, we’re excited to announce that Carrot’s medical team is growing with the addition of G. David Ball, PhD, as Senior Vice President, Medical. Dr. Ball has spent nearly 40 years in the field of reproductive endocrinology and has worked with numerous clinics worldwide to improve clinic success. A leader in assisted reproductive technology, Dr. Ball is the former President of the Society for Assisted Reproductive Technology (SART) and the first PhD to hold this leadership role. SART, the primary organization of professionals dedicated to the practice of ART, represents the majority of IVF clinics in the U.S. These clinics meet the highest standards for quality, safety, and patient care. Dr. Ball continues to work with SART and serves on the executive council.

In his new role, Dr. Ball will report directly to Dr. Ahmad and focus his efforts on understanding the needs of members and customers, and then use that understanding to maximize safer and more successful fertility healthcare through Carrot programs.

Dr. Ball has spent his career auditing IVF labs all over the world to ensure quality and adherence to country guidelines. His leadership and extensive experience with the latest advancements in assisted reproductive technology procedures will enable us to continue to deliver the best experience to our members worldwide.

A renowned embryologist and certified High Complexity Laboratory Director by the American Board of Bioanalysis, Dr. Ball has extensively published his research in peer-reviewed journals and given hundreds of presentations throughout the world on a wide range of topics related to reproductive care.

Prior to joining Carrot, Dr. Ball served as the Director of the Assisted Reproductive Technology Laboratory, simultaneously, at five locations across the U.S. He will maintain three of those sites moving forward. During his career, Dr. Ball has been an active member of several committees and organizations in addition to SART, including The American Society for Reproductive Medicine, the European Society of Human Reproduction and Embryology, and the American Society of Andrology. He has served as the Chair of numerous committees in ART programs over his career including Research and Education, Quality Improvement, and Board of Directors.

We asked Dr. Ball about what brought him to Carrot and what he’s most looking forward to in his new role.

Why did you join Carrot?

Throughout the course of my career, I've been focused on improving the success of IVF treatments and helping people build happy, healthy families. I was drawn to Carrot for the unique opportunity it offers to improve patient access to care. I hope my experience in and understanding of our field can add to those opportunities. I'm excited to work alongside a group of top doctors and medical experts from around the world as we work to make fertility care for all more accessible.

You’ve had a successful career as a lab director. What has been your proudest moment to date?

I’ve had many proud moments but perhaps the most fascinating was years ago when I spoke to the adult daughter of a former patient. I had seen this patient’s daughter under the microscope within hours of fertilization as a one-cell embryo, and seeing her again as an adult made an impact on me and proud of our profession.

Looking ahead five to ten years, do you have any predictions for the future of assisted reproductive technology?

Looking ahead, there will be many developments in this field, some of them profound. I predict we’ll see continued effort to improve embryo quality in the culture stage and in outcomes, the refinement of genetic screening technologies to identify the most developmentally capable embryos, and overall progress in how fertility care is delivered and at what cost it is delivered. These all play into why I’m excited to join Carrot!

To learn more about Carrot and how we support members through their lifelong fertility healthcare journeys, please contact us today.

Any general advice posted on our blog, website, or app is for informational purposes only and is not intended to replace or substitute for any medical advice, diagnosis, or treatment. Carrot Fertility makes no representations or warranties and expressly disclaims any and all liability concerning any treatment, action by, or effect on any person following the general information offered or provided within or through the blog, website, or app.
Read more
Next post
See how Carrot can transform your company
Find out how our customizable fertility solutions can help your plan, your groups, and your members.
Get Started